Shuku Sato < Shumpei Yokota < Shun Kitaba

Facettes : Author.f AffPays.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]

Ident.	Authors (with country if any)	Title
000172 (2020)	Yoshikazu Nakaoka ; Mitsuaki Isobe ; Yoshiya Tanaka ; Tomonori Ishii ; Seido Ooka ; Hiroaki Niiro [Japon] ; Naoto Tamura ; Shogo Banno ; Hajime Yoshifuji [Japon] ; Yasushi Sakata ; Atsushi Kawakami ; Tatsuya Atsumi ; Shunsuke Furuta ; Hitoshi Kohsaka ; Katsuya Suzuki ; Ryoki Hara ; Yasuhiro Maejima ; Hiroshi Tsukamoto ; Yoshinari Takasaki ; Katsuhisa Yamashita ; Norihiro Okada ; Shinji Yamakido ; Syuji Takei ; Shumpei Yokota [Japon] ; Norihiro Nishimoto [Japon]	Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
000932 (2018)	Yoshikazu Nakaoka [Japon] ; Mitsuaki Isobe [Japon] ; Syuji Takei [Japon] ; Yoshiya Tanaka [Japon] ; Tomonori Ishii [Japon] ; Shumpei Yokota [Japon] ; Akira Nomura [Japon] ; Seitaro Yoshida [Japon] ; Norihiro Nishimoto [Japon]	Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study).
000F99 (2016)	Shumpei Yokota [Japon] ; Yasuhiko Itoh [Japon] ; Tomohiro Morio [Japon] ; Hideki Origasa [Japon] ; Naokata Sumitomo [Japon] ; Minako Tomobe [Japon] ; Kunihiko Tanaka [Japon] ; Seiji Minota [Japon]	Tocilizumab in systemic juvenile idiopathic arthritis in a real-world clinical setting: results from 1 year of postmarketing surveillance follow-up of 417 patients in Japan.
001210 (2015)	Shumpei Yokota [Japon] ; Yasuhiko Itoh ; Tomohiro Morio ; Naokata Sumitomo ; Kaori Daimaru ; Seiji Minota	Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab.
001378 (2014)	Takeshi Ikegawa ; Kazuko Yamazaki ; Kenichi Nishimura ; Taichi Kanetaka ; Masako Kikuchi ; Tomo Nozawa ; Ryouki Hara ; Tomomi Sato ; Nodoka Sakurai ; Shumpei Yokota	[A case of severe systemic juvenile idiopathic arthritis introduced tocilizumab in early phase of the disease].
001407 (2015)	Shumpei Yokota [Japon] ; Masako Kikuchi ; Tomo Nozawa ; Taichi Kanetaka ; Tomomi Sato ; Kazuko Yamazaki ; Nodoka Sakurai ; Ryoki Hara ; Masaaki Mori	Pathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome".
001423 (2014)	Chie Aoki ; Yutaka Inaba [Japon] ; Hyonmin Choe ; Utako Kaneko ; Ryoki Hara ; Takako Miyamae ; Tomoyuki Imagawa ; Masaaki Mori ; Mari S. Oba ; Shumpei Yokota ; Tomoyuki Saito	Discrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis.
001457 (2014)	Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu Kishimoto	Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.
001509 (2013)	Tomomi Sato ; Tomo Nozawa ; Taichi Kanetaka ; Masako Kikuchi ; Nodoka Sakurai ; Kazuko Yamazaki ; Takahiro Momoi ; Yoshiyuki Namai ; Shumpei Yokota	2 cases of HLA-B27-positive seronegative spondylarthritides in pediatric age treated with adalimumab.
001549 (2014)	Takako Miyamae [Japon] ; Susumu Yokoya ; Hisashi Yamanaka ; Shumpei Yokota	Effect of tocilizumab on growth impairment in systemic juvenile idiopathic arthritis with long-term corticosteroid therapy.
001764 (2012)	Shumpei Yokota [Japon] ; Toshio Tanaka ; Tadamitsu Kishimoto	Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis.
001767 (2013)	Shumpei Yokota ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu Kishimoto	Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan.
001835 (2013)	Yutaka Inaba [Japon] ; Remi Ozawa ; Chie Aoki ; Tomoyuki Imagawa ; Masaaki Mori ; Ryoki Hara ; Takako Miyamae ; Tomoyuki Saito ; Shumpei Yokota	Radiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis.
001908 (2012)	Toshihiko Shinoki [Japon] ; Ryoki Hara ; Utako Kaneko ; Takako Miyamae ; Tomoyuki Imagawa ; Masaaki Mori ; Shumpei Yokota	Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab.
001A27 (2012)	Tomoyuki Imagawa [Japon] ; Shumpei Yokota ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Hiroyuki Imanaka ; Yasuhito Nerome ; Naomi Iwata ; Takuji Murata ; Mari Miyoshi ; Norihiro Nishimoto ; Tadamitsu Kishimoto	Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis.
001A36 (2011)	Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Syuji Takei ; Takuji Murata ; Minako Tomiita ; Yasuhiko Itoh ; Satoshi Fujikawa ; Masaaki Mori	Guidance on using tocilizumab for juvenile idiopathic arthritis.
001A64 (2011)	Yutaka Inaba ; Remi Ozawa ; Tomoyuki Imagawa ; Masaaki Mori ; Yoshinori Hara ; Takako Miyamae ; Chie Aoki ; Tomoyuki Saito ; Shumpei Yokota	Radiographic improvement of damaged large joints in children with systemic juvenile idiopathic arthritis following tocilizumab treatment.
001B38 (2010)	Shumpei Yokota [Japon] ; Tadamitsu Kishimoto	Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis.
001C58 (2009)	Shoko Nakajima [Japon] ; Takuya Naruto ; Takako Miyamae ; Tomoyuki Imagawa ; Masaaki Mori ; Shigeru Nishimaki ; Shumpei Yokota	Interleukin-6 inhibits early differentiation of ATDC5 chondrogenic progenitor cells.
001D26 (2009)	Shoko Nakajima [Japon] ; Takuya Naruto ; Takako Miyamae ; Tomoyuki Imagawa ; Masaaki Mori ; Shigeru Nishimaki ; Shumpei Yokota	Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab.
001D41 (2008)	Shumpei Yokota	[Interleukin-6 as a pathogenic factor of systemic-onset juvenile idiopathic arthritis].

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i -k "Shumpei Yokota" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/Author.i  \
                -Sk "Shumpei Yokota" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    Shumpei Yokota
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021